Praxis Precision Medicines (PRAX) Misses Q1 EPS by 42c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($3.29), $0.42 worse than the analyst estimate of ($2.87).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Lockheed, RTX, Boeing, L3Harris expected to meet with Trump - WSJ
• Texas AG Paxton announces ongoing investigation into Carnival over data breach